Abstract
The fate of organic micropollutans (MPs) in a membrane system based on microfiltration (MF) and reverse osmosis/nanofiltration (RO/NF) has been investigated for the case of wastewater reuse. Both an operating full-scale water reuse plant and a pilot plant were employed, with 22 individual organic compounds at their ambient concentrations studied for the former and the latter employing two target compounds over a range of feed concentrations. Results revealed removal efficiencies higher than 75% for most compounds in the full-scale plant, though mass flow studies on all streams revealed a significant imbalance of material for some compounds. Rejection efficiencies measured for candidate commercial NF and RO membranes tested at pilot scale challenged with a pharmaceutically active compound (ibuprofen, IBU) and an endocrine-disrupting chemical (nonylphenol, NP) exceeded 99%. Permeate concentrations were 0.005–0.14 μg/L for IBU and below the limit of detection for NP. A mass balance of the MPs for the full-scale plant across the MF and RO stages revealed a significant imbalance associated with the challenge of accurate determination of low concentrations. Differences in pilot plant and full-scale data were otherwise attributed to the impact of membrane ageing (and specifically hydrolysis) on RO rejection of the MPs examined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
